Effect of nicorandil on aortic stiffness in patients with acute coronary syndrome

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CRIS

Registry ID

KCT0001590

Enrollment

Registered

2015-08-07

Start date

2012-08-29

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : experimental group: nicorandil (sigmart) 5 mg twice a day, oral control group: isotril SR ( isosorbide mononitrate) 60 mg, once a day, 8 weeks, oral

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. informed consent before enroll the study 2. 18 year of age or older 3. Patients underwent successful percutaneous transluminal coronary angioplasty due to acute coronary syndrome

Exclusion criteria

Exclusion criteria: 1. less than 90 mmHg of systolic blood pressure 2. women in pregnancy or lactation 3. past history of hypersensitivity or allergy of experimental drug

Design outcomes

Primary

Measure	Time frame
heart-femoral pulse wave velocity	—

Secondary

Measure	Time frame
brachial-ankle pulse wave velocity	—

Countries

Korea, Republic of

Contacts

Public ContactJeong-Sook Seo

Inje University Busan Paik Hospital

orifilter@hanmail.net

Outcome results